Dexmedetomidine is a highly selective α2-adrenoreceptor agonist for sedation of adult critically ill patients which exhibits sedative and analgesic effects. Recent studies suggest that dexmedetomidine to restore adrenergic vasoconstrictor responsiveness in septic shock, and prevents alterations of pain rat model intestinal microcirculation Induced by surgical stress,even it can reduce the mortality of endotoxemic rats and patients with severe sepsis. The investigators preliminary study showed that dexmedetomidine might improve microcirculation in septic shock patients. To test this effect, the investigators will conduct double-blinded study.
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Septic shock patients despite early goal directed therapy
Agree to participate this study
You may not be if
Age\< 18
Pregnancy
Bradycardia (HR\<55bpm)
Systolic Blood Pressure \< 80 mmHg / Mean arterial pressure \< 50 mmHg on maximal support
Death imminent
Unlikely to survive 90 days
Acute liver failure
Dementia
High-grade block in the absence of a functioning pacemaker.